News

Confirm Celiac Diagnosis Before Changing Diet


 

SAN DIEGO – An intestinal biopsy is almost always necessary to confirm celiac disease and is a must before committing a patient to the only effective treatment – a lifelong gluten-free diet.

Rheumatologists are starting to recognize that celiac disease occurs at higher rates in patients with such autoimmune diseases as myositis than in the general population (

Sticking to such a restricted diet is difficult and expensive, Dr. Sheila Crowe said at the meeting. “A lifelong gluten-free diet sounds simple, unless you're the patient. … Eating out is very difficult, especially for children and teens who face a lot of peer pressure. And eating gluten free at home is expensive. Studies in the United States, Canada, and the United Kingdom confirm that a lifelong diet of gluten-free foods costs about three times more than a normal diet,” said Dr. Crowe, professor in the division of gastroenterology and hepatology at the University of Virginia, Charlottesville.

Because treating celiac disease requires this lifelong commitment, a positive serologic test is not enough to rule it in, she said. Nor are any of the available immunologic tests, including the most widely used, tissue transglutaminase IgA (tTG IgA), specific enough to replace intestinal biopsy as the sole method for reliably diagnosing celiac disease. “A positive tTG test is not enough to place a person on this lifelong treatment without confirmation from an intestinal biopsy,” she said. “This is especially important for children, because of the higher likelihood of false positives in that group.”

tTG IgA has a very high sensitivity and specificity, but it is not perfect, Dr. Crowe said. “If you have a patient with clinical symptoms and the tTG comes back negative, there is still a 10% chance that's a false negative. Another scenario could be a patient who has an autoimmune disease or a relative with celiac, and is experiencing celiac symptoms. If the tTG came back negative on that person, I would still do an endoscopy.”

The only possible exception might be a patient with celiac symptoms who already has biopsy-proven dermatitis herpetiformis, with the classic immunofluorescent deposits at the dermal-epidermal junction. “If you biopsy these patients, the intestine will show the changes associated with celiac disease every time,” Dr. Crowe said.

Celiac disease is no longer considered a disorder of childhood. “The disease is there lifelong. It appears you cannot suppress the immune response,” she said.

The intestine rapidly responds to a gluten-free diet, “But the tendency to have an immunologic response to gluten is always there,” Dr. Crowe said.

Relapses are common. Patients are most likely to “fall off” the diet when symptoms begin to abate, she said. They may simply feel “cured” and resume old eating patterns, or they may drop the diet because of changes that can occur as the intestine heals. If patients “had diarrhea and malabsorption of nutrients, they might find themselves getting constipated and gaining weight on the gluten-free diet, fall off, and get ill again. Even if the intestine is healed, the vast majority of data tell us that patients will relapse,” at some point after abandoning the dietary restriction, Dr. Crowe said.

This can lead to the development of refractory celiac disease, in which the intestine fails to recover despite a gluten-free diet. These patients may be unable to fully absorb nutrients and need supplemental feeding methods.

The goal of celiac management is to promote intestinal healing, optimize nutrition, and avoid long-term damage, Dr. Crowe said. “It's key to bring in a knowledgeable dietitian to help. And I mean knowledgeable – not someone who is going to hand your patient a diet sheet and that's all.”

Many celiac patients are already nutritionally compromised at the time of diagnosis. “This is the time to measure their nutritional parameters,” Dr. Crowe said. “They may need supplements. Many are deficient in vitamin D, iron, folate, zinc, or other trace elements.”

The risks of untreated disease “are not inconsequential.” Patients can develop problems related to nutrient malabsorption, including osteopenia, infertility, miscarriage, and intrauterine growth restriction, and are four times more likely than is the general population to develop a malignancy.

Dr. Crowe gets royalties from a book on celiac disease.

Recommended Reading

Consider Celiac Disease in Autoimmune Disorder Patients
MDedge Rheumatology
Don't Taper Glucocorticoids Too Early in Vasculitis
MDedge Rheumatology
Patient Subgroup Response to Belimumab Remains Unclear
MDedge Rheumatology
Bosentan May Reduce Skin Fibrosis in Scleroderma
MDedge Rheumatology
Rituximab Deemed Useful for Certain Lupus Subgroups
MDedge Rheumatology
Socioeconomic Factors Linked to Complications of Giant Cell Arteritis
MDedge Rheumatology
Bortezomib Targets Long-Lived Plasma Cells, Shows Promise for Lupus
MDedge Rheumatology
Be Cautious When Making a Diagnosis of Behçet's Disease
MDedge Rheumatology
Celiac Disease Related to Autoimmune Disorders
MDedge Rheumatology
Ocular Toxicity Rare in Patients Taking Hydroxychloroquine
MDedge Rheumatology